Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03577496 · ClinicalTrials.gov registry record · NA
Does Aromatherapy Decrease Postoperative Nausea and Vomiting?
A NA study of Nausea, Postoperative, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03577496: Completed NA study of Nausea, Postoperative, sponsored by The University of Texas Medical Branch, Galveston.
NCT03577496 is a NA study of Nausea, Postoperative that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03577496, a NA study of Nausea, Postoperative, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Aromatherapy has been proven to be effective for treating patients with postoperative nausea and vomiting (PONV) after surgery, but few studies analyze its effect on preventing PONV. Most studies use aromatherapy once patients become nauseous, but this study will address a gap in the literature with relation to the effect of aromatherapy in the prevention of PONV.
Primary Outcome
Decreased severity of PONV rating with peppermint aromatherapy
Conditions Studied
Interventions
- OTHER Peppermint oil
Study Locations (1)
Texas
- University of Texas Medical Branch - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-06-15 |
| Est. Completion | 2018-12-15 |
| Phase | NA |
What the finished NCT03577496 record still lists
NCT03577496 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Nausea, Postoperative appearing as the primary indexed condition, and to 1 intervention - of which Peppermint oil is the first listed.
NCT03577496 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03577496 about?
NCT03577496 is a clinical study titled "Does Aromatherapy Decrease Postoperative Nausea and Vomiting?". Aromatherapy has been proven to be effective for treating patients with postoperative nausea and vomiting (PONV) after surgery, but few studies analyze its effect on preventing PONV. Most studies use aromatherapy once patients become nauseous, but this study will address a gap in the literature with...
What is the current status of trial NCT03577496?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-06-15. Estimated completion is 2018-12-15.
What conditions does trial NCT03577496 study?
This clinical trial studies the following conditions: Nausea, Postoperative.
What interventions are being tested in trial NCT03577496?
The interventions under investigation include: Peppermint oil (OTHER).
Who is sponsoring clinical trial NCT03577496?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03577496 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03577496's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI